GlaxoSmithKline Pharmaceuticals to hold CME for medical practitioners in Maldives.
GlaxoSmithKline Pharmaceuticals (GSK) will hold a CME program on 23rd May 2008 at Hulhule Island Hotel for medical practitioners in Maldives. The program organised by the Colombo office of Glaxo Wellcome is one in a series of CME programs that have been organised in recent years by the international pharmaceutical company.
Topics and guest speakers:
For more information please contact Mr Muzamil on 07903801
Topics and guest speakers:
- Antibiotic Therapy in Respiratory Tract Infections
Dr Ajith Nagahawatte,
Specialist in Medical Microbiology,
University of Ruhuna, Srilanka - Vaccine- Infancy and Beyond
Dr Omala Wimalaratne,
Consultant Virologist and Vaccinologist,
Medical Research Institute,
Ministry of Health, Srilanka
- Hulhule Island Hotel
- From 7:00pm on 23rd May 2008 (Friday)
For more information please contact Mr Muzamil on 07903801
hmm. so this stuff is starting in Maldives too. *Buy GlaxoSmith products*
Reply to this
Hi DJ, Pharmaceutical companies would carry out promotion of their products everywhere in the world. They have been doing it in Maldives for years, as long as I can remember in fact.
GSK, for obvious reasons would want to market their products too. That they already do. We wanted them to carry out "Continuing Medical Education" programs so that clinician would benefit from the experiences and knowledge of experts in the field. As a multi-national company they have the resources and contacts to organise these kinds of CME lecture series. They have organised such lectures in the past too.
As clinicians it is our duty to question and be content that a medical product is suitable for our patients before we actually prescribe them. This should be based on medical evidence and not just based on who produces them and their marketing. This may be easier said than done.
Having CME where clinician can, as a group listen to medical evidence and rationale- and of course question such evidence and rationale, where needed, provides an opportunity for us to grow as practitioners and to remain up-to-date.
I understand your concerns and I share them too. If this program does not live up to my expectations, as a tool to increase a clinicians knowledge and understanding, I will speak up too.
It is not surprising that GSK has identified topics that are very much related to their products (antibiotics and vaccines). But these are areas we too need to concentrate on. The level of antibiotic abuse is concerning and vaccines have raised several questions both among the public and medical practitioners.
Thanks for your comment.
Reply to this
Big money involved.
Reply to this